General Information of Drug (ID: DMK0AW6)

Drug Name
XOMA-3AB Drug Info
Synonyms Botulism therapy, XOMA; Botulinum type A neurotoxin mAbs (botulism), XOMA; Anti-type A botulinum neurotoxin monoclonal antibodies (botulism), XOMA/NIAID
Indication
Disease Entry ICD 11 Status REF
Clostridium infection 1A04 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMK0AW6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
RT-001 DM3FS1G Acne vulgaris ED80 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Botulinum toxin A (Bact botA) TTB52WU BXA1_CLOBO Not Available [2]

References

1 ClinicalTrials.gov (NCT01357213) Phase 1 PK Study of XOMA 3AB. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of XOMA.
3 Clinical pipeline report, company report or official report of Revance Therapeutics.